Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Toolopen access

Authors
Kim, Ji-WonPark, SunghoonJung, Ju-YangKim, Hyoun-AhKwon, Seong-RyulChoi, Sang TaeKim, Sung-SooKim, Sang-HyeonSuh, Chang-Hee
Issue Date
May-2022
Publisher
MDPI
Keywords
ankylosing spondylitis; osteoporosis; osteoporotic fracture; bone mineral density; fracture risk assessment tool
Citation
JOURNAL OF CLINICAL MEDICINE, v.11, no.10
Journal Title
JOURNAL OF CLINICAL MEDICINE
Volume
11
Number
10
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/59478
DOI
10.3390/jcm11102830
ISSN
2077-0383
2077-0383
Abstract
Background: We investigated the prevalence of and the factors associated with a high risk of osteoporotic fractures in Korean patients with ankylosing spondylitis (AS). Methods: This was a multicenter, retrospective study including 219 AS patients from five university hospitals; the control group was selected by matching age and sex with those of the AS patients. The fracture risk was evaluated based on bone mineral density (BMD) measured by dual-energy X-ray absorptiometry and the fracture risk assessment tool (FRAX) with/without BMD. Results: The mean age of the patients was 47.6 years, and 144 (65.8%) patients were men. According to the WHO criteria and FRAX with/without BMD, the candidates for pharmacological treatment were 44 (20.1%), 20 (13.2%), and 23 (15.1%) patients, respectively, significantly more than those in the healthy control group. Among them, the proportion of patients receiving osteoporosis treatment was 39.1-75%. In logistic regression analysis, menopause was an independent factor for the high risk of fracture according to the WHO criteria and FRAX with/without BMD. C-reactive protein level (odds ratio (OR) 3.8 and OR 6) and glucocorticoid use (OR 1.5 and OR 1.7) were associated with a high risk of osteoporotic fracture based on FRAX without BMD and osteoporosis diagnosed according to the WHO criteria. Conclusions: Our study suggests that both FRAX and WHO criteria may be complementary for treatment decisions to reduce osteoporotic fractures in patients with AS.
Files in This Item
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE